Volume 11, Number 8—August 2005
Research
Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use
Figure 1

Figure 1. . Fluoroquinolone use and resistance over study period. FQ, fluoroquinolone; Levo, levofloxacin; Cipro, ciprofloxacin; Moxi, moxifloxacin; Gati, gatifloxacin; DDD/1,000PD, defined daily doses/1,000 patient-days; FQ-R PSA, fluoroquinolone-resistant Pseudomonas aeruginosa; MRSA, methicillin-resistant Staphylococcus aureus.